MAPRx 2026 Open Enrollment Guide

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Certain people with Medicare can also change plans at other times. Every year plans make changes to benefits and costs. With these different changes, your current plan may or may not be the best plan for you in 2026.

This guide can help find answers to some important questions that can help you during the Annual Open Enrollment.

MAPRx MPPP Patient Guide for 2026

If your prescription drug costs are high, you may benefit from participating in the Medicare Prescription Payment Plan, also known as MPPP. This guide from Medicare Access for Patients Rx describes the Medicare Prescription Payment Plan and helps patients decide if it is right for them.

HealthHIV State of Aging with HIV™ Fourth Annual National Survey

This comprehensive national survey further underscores the ongoing needs and experiences of people aging, thriving, and sometimes struggling with the HIV; many of whom are among the first generation of people diagnosed with HIV.

Highlights from the Fourth Annual State of Aging with HIV Survey

Now in its fourth year, this national survey captures the experiences of people aging with HIV (PAWH) and the professionals who support them.

People on HIV drugs have ‘substantial’ Alzheimer’s protection: study

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA Health investigators now would like clinical trials to examine the potential of the HIV medications as a means to prevent Alzheimer’s disease.

Patients With HIV May Have High Prevalence of Long COVID

The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.

Recommendations for Incorporating Geriatrics Into HIV Care Include Attention to Both Body and Mind

Of the nearly 1.1 million people living with HIV in the United States in 2022, an estimated 54% were over 50 years old, according to the Centers for Disease Control and Prevention (CDC). Yet we are not doing enough to meet the needs of this population: A recent CDC study found that the country was on pace to miss all of its 2025 goals for improving the quality of life for people living with HIV age 50 and older.

Nearly 20% of New HIV Diagnoses Occur Among Older Adults

Patients aged 50 and older who were newly diagnosed with HIV often reported heterosexual transmission and were more often women when compared with those younger than 50, according to an analysis of patients in New York State that was published in JAIDS.

Aging with HIV: Understanding the Journey

Join Gilead Sciences and the American Society on Aging for a series of podcast conversations about caring for older adults living with HIV.

Putting the Brakes on Accelerated Aging of Bone, Muscle from HIV Infection, Treatment

Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.

Brain Aging in HIV Affected by Adverse Social Determinants of Health, Comorbidities

Social determinants of health were found to be associated with brain aging among patients with HIV infection, according to results of a retrospective case-control study published in The Lancet HIV.

Alzheimer’s Disease and Healthy Aging Data Portal

The Alzheimer’s Disease and Healthy Aging Data Portal provides easy access to national and state level CDC data on a range of key indicators of health and well-being for older adults.